| abstract |
Use of "Clostridium botulinum" neurotoxins of types A, B, C, D, E, F or G or a mixture of two or more of these neurotoxins, characterized in that the neurotoxin or neurotoxin mixture is free of complex-forming proteins, which naturally form complexes with botulinum neurotoxins, for the preparation of a drug for cosmetic treatment or for the treatment of dystonia or nervous system conditions in animal or human patients who have already formed neutralizing antibodies against Botulinum neurotoxin complexes. |